What are the major opportunities in the Pneumonia Therapeutics market? What are the strategies for the Pneumonia Therapeutics market?

For detailed insights on the major opportunities and strategies in the Pneumonia Therapeutics market, Read More

How does the Pneumonia Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Pneumonia Therapeutics market growth and SWOT analysis of the Pneumonia Therapeutics industry, Read More

For detailed insights on the mergers and acquisitions in the Pneumonia Therapeutics industry,

What are the key dynamics influencing the Pneumonia Therapeutics market growth? SWOT analysis of the Pneumonia Therapeutics market. Read More

Pneumonia Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Pneumonia Therapeutics Market Report 2026

Name: Pneumonia Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Drugs, Vaccine, Oxygen Therapy ), By Infection (Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Ventilator-Associated Pneumonia (VAP) ), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration ), By End Use (Hospitals, Homecare, Specialty Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Pneumonia Therapeutics Market Overview

• Pneumonia Therapeutics market size has reached to $11.46 billion in 2025

• Expected to grow to $18.83 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%

• Growth Driver: Rising Pneumonia Cases Fuel Demand For Advanced Treatments

• Market Trend: Innovative Approaches To Combating Antibiotic Resistance In Pneumonia Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pneumonia Therapeutics Market?

Pneumonia therapeutics refer to a range of treatments and medications used to manage and treat pneumonia, a lung infection that are caused by bacteria, viruses, or fungi. These therapeutics target the underlying pathogens, reduce inflammation, and improve respiratory functions. Treatments include antibiotics for bacterial pneumonia, antiviral medications for viral pneumonia, and antifungal agents for fungal infections.

The main products of pneumonia therapeutics are drugs, vaccines, and oxygen therapy. Drugs for pneumonia therapeutics address the root cause (bacteria, viruses, or fungi) and alleviate symptoms through antibiotics, antivirals, antifungals, and supportive treatments such as oxygen therapy. The infections treated comprise hospital-acquired pneumonia (HAP), community-acquired pneumonia (CAP), and ventilator-associated pneumonia (VAP). The routes of administration include oral, parenteral, and other methods and are used by end users such as hospitals, home care, specialty clinics, and others.

Pneumonia Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Pneumonia Therapeutics Market Size and Share 2026?

The pneumonia therapeutics market size has grown rapidly in recent years. It will grow from $11.46 billion in 2025 to $12.68 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increasing incidence of respiratory infections, rising hospitalization rates for pneumonia, widespread use of antibiotics, expansion of intensive care infrastructure, growing elderly population.

What Is The Pneumonia Therapeutics Market Growth Forecast?

The pneumonia therapeutics market size is expected to see rapid growth in the next few years. It will grow to $18.83 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing development of novel antibiotics and antivirals, rising adoption of rapid diagnostic testing, growing focus on antimicrobial resistance management, expansion of homecare pneumonia treatment models, increasing investment in vaccine-based prevention strategies. Major trends in the forecast period include increasing adoption of targeted antimicrobial therapies, rising use of combination drug regimens, growing focus on early pathogen identification, expansion of home-based oxygen therapy solutions, enhanced emphasis on hospital infection control protocols.

Book your 30 minutes free consultation with our research experts

Global Pneumonia Therapeutics Market Segmentation

1) By Product: Drugs, Vaccine, Oxygen Therapy

2) By Infection: Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Ventilator-Associated Pneumonia (VAP)

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By End Use: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Drugs: Antibiotics, Antiviral Drugs, Antifungal Drugs, Corticosteroids

2) By Vaccine: Pneumococcal Vaccines, Haemophilus Influenzae Type B (Hib) Vaccines, Influenza Vaccines

3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC), Non-Invasive Ventilation (NIV), Mechanical Ventilation

What Is The Driver Of The Pneumonia Therapeutics Market?

The rising prevalence of pneumonia is expected to drive the growth of the pneumonia therapeutics market going forward. Pneumonia refers to a lung infection that inflames the air sacs, often causing symptoms such as cough, fever, and difficulty breathing. Increasing pneumonia cases can be attributed to factors such as aging populations, air pollution, smoking, weakened immune systems, antimicrobial resistance, and the spread of respiratory infections like COVID-19 or influenza. Pneumonia therapeutics help to combat the infection's cause, such as bacteria, viruses, or fungi, using targeted medications while supporting recovery through oxygen therapy, anti-inflammatory drugs, and symptom management. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based government agency, globally, pneumonia affects about 120 million people annually, causing approximately 1.3 million deaths. Nearly 80% of pediatric pneumonia deaths occur in children under 2 in developing countries. Therefore, the increasing prevalence of pneumonia is driving the growth of the pneumonia therapeutics industry.

Key Players In The Global Pneumonia Therapeutics Market

Major companies operating in the pneumonia therapeutics market are Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc.

Global Pneumonia Therapeutics Market Trends and Insights

Major companies operating in the pneumonia therapeutics market focus on developing innovative drug formulations and treatment methods such as antibiotic drugs to address antibiotic resistance and improve patient outcomes. An antibiotic drug refers to a type of medication specifically designed to treat bacterial infections. For instance, in June 2024, Orchid Pharma Limited, an India-based pharmaceutical company, collaborated with Cipla Limited, an India-based pharmaceutical company, to introduce cefepime-enmetazobactam. This antibiotic combination is used to treat complex infections, including UTIs and pneumonia, particularly those resistant to other medications. It helps combat bacterial resistance, ensuring effective treatment while minimizing the need for stronger antibiotics.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Pneumonia Therapeutics Market?

In June 2023, Novo Holdings and Gurnet Point Capital, US-based investment firms, acquired Paratek Pharmaceuticals, Inc. for approximately US$462 million. Through this acquisition, the firms gained ownership of Paratek’s antibiotic portfolio, including Nuzyra (omadacycline), an FDA-approved treatment for community-acquired bacterial pneumonia (CABP), thereby strengthening their presence in the pneumonia therapeutics market. Paratek Pharmaceuticals, Inc. is a US-based biopharmaceutical company that provides antibiotic therapies, notably Nuzyra, available in both oral and intravenous formulations for the treatment of bacterial pneumonia.

Regional Outlook

North America was the largest region in the pneumonia therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pneumonia Therapeutics Market?

The pneumonia therapeutics market consists of revenues earned by entities by providing services such as chest X-rays, blood tests, sputum culture, oxygen supplementation, mechanical ventilation, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The pneumonia therapeutics market also includes sales of pneumococcal vaccines, antibiotics, nebulizers, and inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pneumonia Therapeutics Market Report 2026?

The pneumonia therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pneumonia therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pneumonia Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$12.68 billion
Revenue Forecast In 2035	$18.83 billion
Growth Rate	CAGR of 10.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Infection, Route Of Administration, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pneumonia Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pneumonia Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pneumonia Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pneumonia Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Antimicrobial Therapies

4.2.2 Rising Use Of Combination Drug Regimens

4.2.3 Growing Focus On Early Pathogen Identification

4.2.4 Expansion Of Home-Based Oxygen Therapy Solutions

4.2.5 Enhanced Emphasis On Hospital Infection Control Protocols

5. Pneumonia Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Providers

5.4 Long-Term Care Facilities

5.5 Emergency Care Centers

6. Pneumonia Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pneumonia Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pneumonia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pneumonia Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pneumonia Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pneumonia Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pneumonia Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pneumonia Therapeutics Market Segmentation

9.1. Global Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drugs, Vaccine, Oxygen Therapy

9.2. Global Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Ventilator-Associated Pneumonia (VAP)

9.3. Global Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Routes Of Administration

9.4. Global Pneumonia Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End Users

9.5. Global Pneumonia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibiotics, Antiviral Drugs, Antifungal Drugs, Corticosteroids

9.6. Global Pneumonia Therapeutics Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pneumococcal Vaccines, Haemophilus Influenzae Type B (Hib) Vaccines, Influenza Vaccines

9.7. Global Pneumonia Therapeutics Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

High-Flow Nasal Cannula (HFNC), Non-Invasive Ventilation (NIV), Mechanical Ventilation

10. Pneumonia Therapeutics Market Regional And Country Analysis

10.1. Global Pneumonia Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pneumonia Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pneumonia Therapeutics Market

11.1. Asia-Pacific Pneumonia Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pneumonia Therapeutics Market

12.1. China Pneumonia Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pneumonia Therapeutics Market

13.1. India Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pneumonia Therapeutics Market

14.1. Japan Pneumonia Therapeutics Market Overview

14.2. Japan Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pneumonia Therapeutics Market

15.1. Australia Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pneumonia Therapeutics Market

16.1. Indonesia Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pneumonia Therapeutics Market

17.1. South Korea Pneumonia Therapeutics Market Overview

17.2. South Korea Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pneumonia Therapeutics Market

18.1. Taiwan Pneumonia Therapeutics Market Overview

18.2. Taiwan Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pneumonia Therapeutics Market

19.1. South East Asia Pneumonia Therapeutics Market Overview

19.2. South East Asia Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pneumonia Therapeutics Market

20.1. Western Europe Pneumonia Therapeutics Market Overview

20.2. Western Europe Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pneumonia Therapeutics Market

21.1. UK Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pneumonia Therapeutics Market

22.1. Germany Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pneumonia Therapeutics Market

23.1. France Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pneumonia Therapeutics Market

24.1. Italy Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pneumonia Therapeutics Market

25.1. Spain Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pneumonia Therapeutics Market

26.1. Eastern Europe Pneumonia Therapeutics Market Overview

26.2. Eastern Europe Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pneumonia Therapeutics Market

27.1. Russia Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pneumonia Therapeutics Market

28.1. North America Pneumonia Therapeutics Market Overview

28.2. North America Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pneumonia Therapeutics Market

29.1. USA Pneumonia Therapeutics Market Overview

29.2. USA Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pneumonia Therapeutics Market

30.1. Canada Pneumonia Therapeutics Market Overview

30.2. Canada Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pneumonia Therapeutics Market

31.1. South America Pneumonia Therapeutics Market Overview

31.2. South America Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pneumonia Therapeutics Market

32.1. Brazil Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pneumonia Therapeutics Market

33.1. Middle East Pneumonia Therapeutics Market Overview

33.2. Middle East Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pneumonia Therapeutics Market

34.1. Africa Pneumonia Therapeutics Market Overview

34.2. Africa Pneumonia Therapeutics Market, Segmentation By Product, Segmentation By Infection, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pneumonia Therapeutics Market Regulatory and Investment Landscape

36. Pneumonia Therapeutics Market Competitive Landscape And Company Profiles

36.1. Pneumonia Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pneumonia Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pneumonia Therapeutics Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Pneumonia Therapeutics Market Other Major And Innovative Companies

Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd

38. Global Pneumonia Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pneumonia Therapeutics Market

40. Pneumonia Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Pneumonia Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Pneumonia Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Pneumonia Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Pneumonia Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Pneumonia Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Pneumonia Therapeutics Market, Supply Chain Analysis

Table 4: Global Pneumonia Therapeutics Market, Major Raw Material Providers

Table 5: Global Pneumonia Therapeutics Market, Major Resource Providers

Table 6: Global Pneumonia Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Pneumonia Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Pneumonia Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Pneumonia Therapeutics Market, Major Trends

Table 10: Global Pneumonia Therapeutics Market, Major End Users

Table 11: Global Pneumonia Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Pneumonia Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Pneumonia Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Pneumonia Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Pneumonia Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Pneumonia Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Pneumonia Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Pneumonia Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Pneumonia Therapeutics Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: Roche AG Financial Performance

Table 100: Merck & Co. Inc. Financial Performance

Table 101: AbbVie Inc Financial Performance

Table 102: Bayer AG Financial Performance

Table 103: Global Pneumonia Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Pneumonia Therapeutics Market, Competitive Dashboard

Table 105: Global Pneumonia Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Pneumonia Therapeutics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 107: Global, Pneumonia Therapeutics Market Size Gain ($ Billion), Segmentation By Infection, 2025 – 2030

Table 108: Global, Pneumonia Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Pneumonia Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Pneumonia Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Pneumonia Therapeutics Market, Supply Chain Analysis

Figure 4: Global Pneumonia Therapeutics Market, Major Raw Material Providers

Figure 5: Global Pneumonia Therapeutics Market, Major Resource Providers

Figure 6: Global Pneumonia Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Pneumonia Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Pneumonia Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Pneumonia Therapeutics Market, Major Trends

Figure 10: Global Pneumonia Therapeutics Market, Major End Users

Figure 11: Global Pneumonia Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Pneumonia Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Pneumonia Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Pneumonia Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Pneumonia Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Pneumonia Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Pneumonia Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Pneumonia Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Pneumonia Therapeutics Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: Roche AG Financial Performance

Figure 100: Merck & Co. Inc. Financial Performance

Figure 101: AbbVie Inc Financial Performance

Figure 102: Bayer AG Financial Performance

Figure 103: Global Pneumonia Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Pneumonia Therapeutics Market, Competitive Dashboard

Figure 105: Global Pneumonia Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Pneumonia Therapeutics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 107: Global, Pneumonia Therapeutics Market Size Gain ($ Billion), Segmentation By Infection, 2025 – 2030

Figure 108: Global, Pneumonia Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Lower Respiratory Tract Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Asthma, Chronic Obstructive Pulmonary Disease, Pneumonia, Tuberculosis, Bronchitis, Other Diseases), By Drug Class (Antibiotics,...

Anti-Inflammatory Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics), By Indication (Arthritis, Respiratory Dise...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Vaginitis Therapeutics Market Report 2026 - Global Outlook – By Drug Type (Nitroimidazole Compound, Lincosamide Antibiotics, Triazoles, Imidazoles), By Route Of Administration (Oral, Cutaneous, Vaginal), By Indication Ty...

Pneumococcal Vaccine Market Report 2026 - Global Outlook – By Product Type (Prevnar 13, Synflorix, Pneumovax23, Other Products), By Route of Administration (Intravenous, Intramuscular, Subcutaneous), By Distribution Chan...

Bronchitis Treatment Market Report 2026 - Global Outlook – By Type (Acute Bronchitis, Chronic Bronchitis), By Treatment (Drugs, Oxygen Therapy), By Distribution Channel (Online Pharmaceutical Stores, Retail Pharmacies, H...

Frequently Asked Questions

How big is the Pneumonia Therapeutics Market?

The Pneumonia Therapeutics market was valued at $11.46 billion in 2025, increased to $12.68 billion in 2026, and is projected to reach $18.83 billion by 2030.

What is the Pneumonia Therapeutics market growth?

The global Pneumonia Therapeutics market is expected to grow at a CAGR of 10.4% from 2026 to 2035 to reach $18.83 billion by 2035.

Who are the key players in Pneumonia Therapeutics market?

Some Key Players in the Pneumonia Therapeutics market Include, Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc. .

What is the anticipated growth trend for the Pneumonia Therapeutics market?

Major trend in this market includes: Innovative Approaches To Combating Antibiotic Resistance In Pneumonia Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the Pneumonia Therapeutics market?

North America was the largest region in the pneumonia therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumonia therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.